Dr. Joanne Kwak-Kim to Showcase Advances in Reproductive Immunology at ASRM 2025
In an exciting development within the field of reproductive health, Dr. Joanne Kwak-Kim, the esteemed director of the Reproductive Medicine and Immunology program at Rosalind Franklin University (RFU), has been announced as a featured speaker for the upcoming American Society of Reproductive Medicine (ASRM) Congress in 2025, which will take place in San Antonio, Texas. Dr. Kwak-Kim brings over three decades of expertise in aiding women experiencing recurrent pregnancy loss and implantation challenges, an area of focus she will delve into at the conference.
Her presentation will center on a vital aspect of reproductive immunology: the "Endometrial Tissue Analysis Decidualization Score Test and New Emerging Markers." This study seeks to uncover the maternal immune environment's impact on implantation success, aiming to shed light on the reasons behind pregnancy failures and enhance early gestation support. Dr. Kwak-Kim emphasizes the importance of identifying markers linked to decidualization and endometrial receptivity, stating, "By identifying key markers of decidualization and endometrial receptivity, we move closer to unlocking why some pregnancies fail and how we can better support early gestation."
Dr. Kwak-Kim's impressive background has made her a leading authority in reproductive immunology, with an astounding record of 198 peer-reviewed publications and contributions to multiple book chapters. Additionally, her legacy includes serving as a past president of the American Society for Reproductive Immunology, further underscoring her pivotal role in advancing knowledge in this crucial field.
Another notable figure at the ASRM is Dr. Svetlana Dambaeva, director of RFU's Clinical Immunology Laboratory, who will collaborate with Dr. Kwak-Kim by presenting four studies during the poster sessions. These studies include significant findings on the Association between Anti-Mullerian Hormone and endometrial natural killer cell profiles in women facing reproductive difficulties, among others. Their collaborative work brings together groundbreaking research that seeks to push the boundaries of reproductive medicine further.
Together, they explore critical topics such as the pathology of immune responses during pregnancy. Their recent publication, titled "The Dual Role of Interleukin-22 Balancing Protection and Risk In Pregnancy During Inflammatory Challenges", published in the renowned journal Fertility and Sterility, reveals the potential of Interleukin-22 as a therapeutic target. The study highlights the delicate immune balance necessary for pregnancy success, indicating that while IL-22 may offer protection, elevated levels could lead to reproductive failures.
Dr. Joseph DiMario, RFU's Executive Vice President for Research, articulated the strength of the university's comprehensive approach to reproductive medicine, affirming that the integration of their Reproductive Medicine Clinic, Clinical Immunology Laboratory, and basic science research centers provides cutting-edge diagnostic and treatment options for women with histories of implantation failure. He notes that the university supports around 260 clinics across 30 countries, conducting over 40,000 specialized tests annually.
The ASRM Congress serves as a major platform for clinicians and researchers alike, gathering top minds in reproductive medicine to discuss advancements encompassing various aspects of reproductive health from infertility treatments to menopause and innovative cryopreservation techniques. This year's gathering is anticipated to foster enriching discussions and breakthroughs that will shape the future landscape of reproductive health.
Rosalind Franklin University remains committed to advancing the field of medicine as a whole through its dedication to imparting high-quality interprofessional education and achieving significant research outcomes aimed at improving overall health and wellness. The university honors its namesake, Dr. Rosalind Franklin, a leading scientist known for her critical contributions to DNA research, by continually promoting inquiry and excellence in biomedical education. RFU encompasses several accredited programs including the Chicago Medical School and the College of Health Professions, among others, emphasizing a multi-disciplinary approach to health education and research focuses, such as reproductive immunology, diabetes, and neuroscience.
For more information about the event or the research conducted at RFU, you can visit their official website at rosalindfranklin.edu.
Her presentation will center on a vital aspect of reproductive immunology: the "Endometrial Tissue Analysis Decidualization Score Test and New Emerging Markers." This study seeks to uncover the maternal immune environment's impact on implantation success, aiming to shed light on the reasons behind pregnancy failures and enhance early gestation support. Dr. Kwak-Kim emphasizes the importance of identifying markers linked to decidualization and endometrial receptivity, stating, "By identifying key markers of decidualization and endometrial receptivity, we move closer to unlocking why some pregnancies fail and how we can better support early gestation."
Dr. Kwak-Kim's impressive background has made her a leading authority in reproductive immunology, with an astounding record of 198 peer-reviewed publications and contributions to multiple book chapters. Additionally, her legacy includes serving as a past president of the American Society for Reproductive Immunology, further underscoring her pivotal role in advancing knowledge in this crucial field.
Another notable figure at the ASRM is Dr. Svetlana Dambaeva, director of RFU's Clinical Immunology Laboratory, who will collaborate with Dr. Kwak-Kim by presenting four studies during the poster sessions. These studies include significant findings on the Association between Anti-Mullerian Hormone and endometrial natural killer cell profiles in women facing reproductive difficulties, among others. Their collaborative work brings together groundbreaking research that seeks to push the boundaries of reproductive medicine further.
Together, they explore critical topics such as the pathology of immune responses during pregnancy. Their recent publication, titled "The Dual Role of Interleukin-22 Balancing Protection and Risk In Pregnancy During Inflammatory Challenges", published in the renowned journal Fertility and Sterility, reveals the potential of Interleukin-22 as a therapeutic target. The study highlights the delicate immune balance necessary for pregnancy success, indicating that while IL-22 may offer protection, elevated levels could lead to reproductive failures.
Dr. Joseph DiMario, RFU's Executive Vice President for Research, articulated the strength of the university's comprehensive approach to reproductive medicine, affirming that the integration of their Reproductive Medicine Clinic, Clinical Immunology Laboratory, and basic science research centers provides cutting-edge diagnostic and treatment options for women with histories of implantation failure. He notes that the university supports around 260 clinics across 30 countries, conducting over 40,000 specialized tests annually.
The ASRM Congress serves as a major platform for clinicians and researchers alike, gathering top minds in reproductive medicine to discuss advancements encompassing various aspects of reproductive health from infertility treatments to menopause and innovative cryopreservation techniques. This year's gathering is anticipated to foster enriching discussions and breakthroughs that will shape the future landscape of reproductive health.
Rosalind Franklin University remains committed to advancing the field of medicine as a whole through its dedication to imparting high-quality interprofessional education and achieving significant research outcomes aimed at improving overall health and wellness. The university honors its namesake, Dr. Rosalind Franklin, a leading scientist known for her critical contributions to DNA research, by continually promoting inquiry and excellence in biomedical education. RFU encompasses several accredited programs including the Chicago Medical School and the College of Health Professions, among others, emphasizing a multi-disciplinary approach to health education and research focuses, such as reproductive immunology, diabetes, and neuroscience.
For more information about the event or the research conducted at RFU, you can visit their official website at rosalindfranklin.edu.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.